Aurum Laboratories, a subsidiary of Explora Biotech Srl, is a new kind of partner for companies developing next-generation advanced-therapy medicinal products (ATMP).
Advanced therapy medicinal products (ATMPs) are gene- or cell-based medicines for human use. These new medicines offer groundbreaking opportunities to help patients being treated for disease or recovering from injury. However, ATMPs also pose technical and regulatory challenges in development that increase the risks for companies wanting to bring these products to market.
Aurum Laboratories is able to support customers from the prototype-stage onwards. We are one of the first Contract Research Organisations (CROs) to offer a comprehensive and integrated portfolio of services – from study design to the preclinical validation of ATMPs.
We work with all types of product, including gene therapy, somatic cells, tissue engineered and regenerative medicine, as well as combined ATMPs.
As a comprehensive testing partner, Aurum Laboratories is a single-supplier source for all of your testing needs, from mechanical testing, to in-vivo safety and efficacy, to material characterization and microbiological evaluation.